EODData

FRA, RYH0: SAREUM HLDGS LS-0125

31 Mar 2026
LAST:

0.1460

CHANGE:
 0.00
OPEN:
0.1340
HIGH:
0.1460
ASK:
0.0000
VOLUME:
0
CHG(%):
0.00
PREV:
0.1460
LOW:
0.1340
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
31 Mar 260.13400.14600.13400.14600
30 Mar 260.13800.14600.13800.14600
27 Mar 260.13900.14700.13900.14700
26 Mar 260.14300.15700.14300.1570847
25 Mar 260.13400.15700.13400.1570847
24 Mar 260.13500.14700.13500.1470847
23 Mar 260.13400.14700.13400.1470847
20 Mar 260.13500.14700.13500.1470847
19 Mar 260.13900.14700.13900.14700
18 Mar 260.13500.14700.13500.14700

PROFILE

Name:SAREUM HLDGS LS-0125
About:Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also involves in developing SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical stage for cancer and cancer-immunotherapy applications; and SRA737, a clinical-stage oral, selective Checkpoint kinase 1 inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. Sareum Holdings plc was formerly known as Keepfast plc and changed its name to Sareum Holdings plc in July 2004. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:Langford Arch, Cambridge, United Kingdom, CB22 3FX
Website:https://www.sareum.com
ISIN:GB00BMC3RJ87
LEI:213800PKERN2DY8FFM72

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-3.43 
Price to Book:7.90 
Return on Assets:-0.60 
Return on Equity:-2.02 
Shares:137.22M 
Market Cap:20.03M 

TECHNICAL INDICATORS

MA5:0.153.2%
MA10:0.151.9%
MA20:0.141.8%
MA50:0.156.0%
MA100:0.154.7%
MA200:0.1719.0%
STO14:62.07
RSI14:72.50 
WPR14:-37.93
MTM14:0.02
ROC14:0.14 
ATR:0.01 
Week High:0.167.5%
Week Low:0.139.0%
Month High:0.167.5%
Month Low:0.1219.0%
Year High:0.2891.8%
Year Low:0.07108.6%
Volatility:79.16 

RECENT SPLITS

Date Ratio
01 Mar 20221-50